QIAGEN Gruppe

QIAGEN Gruppe is a leading global provider of sample and assay technologies, dedicated to transforming biological samples into valuable insights. Founded in 1986, the company has established itself as a pioneer in the field of molecular diagnostics and life sciences.

With a strong commitment to innovation, QIAGEN develops products that enable researchers and healthcare professionals to unlock the potential of genomic information. The company’s extensive portfolio includes solutions for DNA, RNA, and protein extraction, as well as a wide range of assays for various applications.

Core Activities:

• Molecular Diagnostics: QIAGEN offers a comprehensive suite of diagnostic tests that aid in the detection and monitoring of diseases.
• Life Sciences: The company provides tools and technologies that support research in genomics, proteomics, and other areas of life sciences.
• Bioinformatics: QIAGEN integrates bioinformatics solutions to help researchers interpret complex data and make informed decisions.

Headquartered in the UK, QIAGEN operates in over 25 countries, serving customers in more than 150 countries worldwide. The company is committed to sustainability and ethical practices, ensuring that its operations have a positive impact on society and the environment.

QIAGEN’s vision is to empower scientists and healthcare professionals with the tools they need to improve human health and advance scientific discovery. Through continuous investment in research and development, the company aims to remain at the forefront of innovation in the life sciences industry.